Cencora to Acquire EyeSouth Partners' Retina Business for $1.1 Billion, Expanding RCA
COR sits 24% above its 52-week low of $264.33 on elevated volume (2.4× avg).
Summary
Cencora is acquiring EyeSouth Partners' retina business for $1.1 billion to expand its Retina Consultants of America, a move expected to be accretive to EPS.
Key Events · M&A and Partnerships · COR
-
Strategic Acquisition Announced
Cencora entered a definitive agreement on March 21, 2026, to acquire EyeSouth Partners' retina business for $1.1 billion.
-
Expansion of Retina Consultants of America
The acquisition will integrate EyeSouth Partners' retina physicians into Cencora's Retina Consultants of America (RCA), strengthening its management services organization network.
-
Expected Financial Impact
The transaction is anticipated to be slightly accretive to Cencora's adjusted diluted EPS within the first twelve months post-closing, net of financing costs.
-
Fiscal 2026 Guidance Reaffirmed
Cencora reaffirmed its fiscal 2026 financial guidance, noting that the acquisition is not yet factored into the current outlook.
Analysis · COR · Trade & Services
This 8-K announces Cencora's definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion, a strategic move to expand its Retina Consultants of America (RCA) management services organization. The acquisition is expected to be slightly accretive to adjusted diluted EPS within the first year post-closing, reinforcing Cencora's commitment to community physicians and advancing sight-saving treatments. The company's reaffirmation of fiscal 2026 guidance suggests confidence in its overall financial outlook despite this significant transaction.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1045 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, COR was trading at $326.76 on NYSE in the Trade & Services sector, with a market capitalization of approximately $63.6B. The 52-week trading range was $264.33 to $377.54. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.